The envisioned flow cytometry test will help to predict patient response to immunotherapies for five cancer indications.

NEW YORK — Genedrive said on Friday that it has received CE marking under the EU's In Vitro Diagnostic Medical Device Regulation (IVDR) for its point-of-care CYP2C19 ID Kit genotyping platform, which ...

The London-based firm will provide its CIZ1B lung cancer test and DEX-G2 gastric cancer test for use in Doctors Hospital in the Cayman Islands.

The companies will develop and commercialize diagnostic tools to help clinicians determine which patients would benefit from precision medicine treatments.

The company's flagship assay uses whole-genome sequencing to identify patients with high-risk multiple myeloma and determine which patients won't respond to therapies.

The firm touted new assays, provided an update on its nanopore sequencer, and offered insights into upcoming pipeline ...

NEW YORK – Agilent Technologies reported after the close of the market on Wednesday that its fiscal Q2 diagnostics and life sciences revenues jumped 8 percent year over year with growth in its ...

The firm's shares rose to $62.17 at the close of Tuesday's trading on news that TPG and Blackstone had offered to take the firm private.

Investors and consultants in the space said that they have seen rising enthusiasm among investors as recent funding rounds ...

NEW YORK – The US Food and Drug Administration said Tuesday that it has issued a warning letter to German medical supply firm Kabe Labortechnik regarding the manufacturing of its SAFE-T-FILL Capillary ...